1. Factors predicting improvement in motor disability in writer's cramp treated with botulinum toxin
- Author
-
Jean-Sébastien Vidal, S T du Montcel, R Djebbari, G Gallouedec, Sangla S, and M. Vidailhet
- Subjects
musculoskeletal diseases ,Paper ,Adult ,Male ,Handwriting ,medicine.medical_specialty ,Botulinum Toxins ,Neuromuscular disease ,genetic structures ,Severity of Illness Index ,complex mixtures ,Physical medicine and rehabilitation ,Predictive Value of Tests ,Severity of illness ,medicine ,Humans ,Aged ,Dystonia ,Anti-Dyskinesia Agents ,business.industry ,Writer's cramp ,Middle Aged ,Hand ,Prognosis ,medicine.disease ,Botulinum toxin ,nervous system diseases ,body regions ,Clinical trial ,Psychiatry and Mental health ,Treatment Outcome ,Dystonic Disorders ,Physical therapy ,Female ,Surgery ,Neurology (clinical) ,business ,Dystonic disorder ,medicine.drug - Abstract
Objective: To identify factors predicting improvement in motor disability in writer's cramp treated with botulinum toxin (BTX). Methods: 47 patients with writer's cramp were treated with BTX and were evaluated by the same neurologists at initial referral, after each BTX injection, and when the effect of BTX was maximal at the time of the study. Patients and examiners simultaneously and independently rated the efficacy of BTX injections. Self assessment was a global clinical impression of the impact of treatment on writing quality, writing speed, writing errors, and legibility of handwriting; for objective assessment, the examiners used the Burke-Fahn-Marsden (BFM) scale. Results: On the BFM scale, there was a significant improvement (p
- Published
- 2004